Spasticity Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PSIL | F | AdvisorShares Psychedelics ETF | 4.98 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.14 | |
FBT | A | First Trust Amex Biotech Index Fund | 3.68 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 3.06 | |
PSCH | D | PowerShares S&P SmallCap Health Care Portfolio | 2.93 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Oct 2 | ALKS | Alkermes (NASDAQ:ALKS) shareholder returns have been favorable, earning 62% in 5 years |
- Spasticity
Spasticity (from Greek spasmos- 'drawing, pulling') is a feature of altered skeletal muscle performance with a combination of paralysis, increased tendon reflex activity, and hypertonia. It is also colloquially referred to as an unusual "tightness", stiffness, or "pull" of muscles.
Clinically, spasticity results from the loss of inhibition of motor neurons, causing excessive velocity-dependent muscle contraction. This ultimately leads to hyperreflexia, an exaggerated deep tendon reflex. Spasticity is often treated with the drug baclofen, which acts as an agonist at GABA receptors, which are inhibitory.
Spastic cerebral palsy is the most common form of cerebral palsy, which is a group of permanent movement problems that do not get worse over time. GABA's inhibitory actions contribute to baclofen's efficacy as an anti-spasticity agent.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles